OTC · Medical - Pharmaceuticals

MedGen, Inc. (MDIN) Stock

$0.00 OTC: MDIN Healthcare

On June 25, 2020, MedGen, Inc. acquired 9430075 Canada Ltd.

Valuation

MetricValue
Price$0.00
Market Cap$90309
P/E Ratio-600.00
P/B Ratio-217.64
P/S Ratio1.02
EPS (TTM)$-147.78
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE36.27%
ROA0.00%
ROCE35.62%
Gross Margin100.00%
Operating Margin-1478.50%
Net Margin0.00%
Debt/Equity-0.57
Current Ratio0.00

Annual Financials (USD)

Metric201620172019
Revenue$0$0$0
Operating Profit$0$0$0
Net Profit$-1.0M$0$0
EPS$0.00$0.00$0.00
Op Margin

Balance Sheet (USD)

Metric201620172019
Total Assets$0
Total Liabilities$0
Cash$0
Borrowings$0$0$0

Cash Flow (USD)

Metric201620172019
Operating Cash Flow$0$0
Investing Cash Flow$0$0
Financing Cash Flow$0$0
Net Cash Flow$0$0
Free Cash Flow$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-6.00
EV / EBITDA-5875.73
FCF Yield-0.02%
Quick Ratio0.00
Interest Coverage0.00
Return 1Y0.00%
Return 3Y0.00%
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AREVFAREV Life Sciences Global Corp $0.00 -1.87 $15881 0.00%
CHNXFChitogenX Inc. $0.01 +0.00% -0.23 $627628 0.00%
HMPQHempAmericana, Inc $0.00 -0.50 $291753 0.00%
INQDIndoor Harvest Corp. $0.00 -0.09 $320570 0.00%
LFCOFLift & Co. Corp. $0.00 -0.01 $63446 0.00%

About MedGen, Inc.

On June 25, 2020, MedGen, Inc. acquired 9430075 Canada Ltd. through a reverse merger transaction. Founded in 2015 and based in Winnipeg, Canada, 9430075 Canada Ltd. manages a digital health and wellness platform. This platform serves two primary functions: it assists individuals in finding vital health information and referrals, and it allows health and wellness professionals to directly engage with clients.

MedGen, Inc. (MDIN) stock trades at $0.00 with a market capitalization of $90309. The stock is valued at a price-to-earnings (P/E) ratio of -600.00, price-to-book of -217.64, price-to-sales of 1.02. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, MedGen, Inc. generates a return on equity (ROE) of 36.27% — well above the market average, a sign of a high-quality business, return on capital employed of 35.62%, an operating margin of -1478.50%, a net profit margin of 0.00%.

Official website: www.magnifind.ca

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides